Search Results for: KAT8

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
KMT2A lysine methyltransferase 2A
  • PKMTs methylate histone lysines
  • RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • Transcriptional regulation of granulopoiesis
  • Formation of WDR5-containing histone-modifying complexes
  • Regulation of PD-L1(CD274) transcription
  • Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes
  • Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters
  • The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex
  • Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia)
  • Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)
PAF1 PAF1 component of Paf1/RNA polymerase II complex
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Pre-transcription Events
  • RNA Polymerase II Transcription Elongation
  • E3 ubiquitin ligases ubiquitinate target proteins
PLAU plasminogen activator, urokinase
  • Neutrophil degranulation
  • Dissolution of Fibrin Clot
  • Amiloride
  • 2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide
  • 2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine
  • 6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine
  • 2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine
  • 6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine
  • 6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine
  • CRA_10655
  • 6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine
  • 6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine
  • 7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide
  • 6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide
  • Benzamidine
  • 4-Iodobenzo[B]Thiophene-2-Carboxamidine
  • CRA_8696
  • Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine
  • 2-Amino-1H-benzimidazol-5-ol
  • N-(1-adamantyl)-N'-(4-guanidinobenzyl)urea
  • 6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine
  • Thieno[2,3-B]Pyridine-2-Carboxamidine
  • 8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide
  • [2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine
  • Fibrinolysin
  • 6-fluoro-2-(2-hydroxy-3-isobutoxy-phenyl)-1H-benzoimidazole-5-carboxamidine
  • 6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE
  • N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE
  • 6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE
  • 1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine
  • (2R)-1-(2,6-dimethylphenoxy)propan-2-amine
  • 4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide
  • 4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide
  • 4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE
  • 4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide
RNF2 ring finger protein 2
  • Oxidative Stress Induced Senescence
  • SUMOylation of DNA damage response and repair proteins
  • SUMOylation of transcription cofactors
  • SUMOylation of chromatin organization proteins
  • SUMOylation of RNA binding proteins
  • SUMOylation of DNA methylation proteins
  • RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
  • Regulation of PTEN gene transcription
  • Regulation of PTEN gene transcription
  • Transcriptional Regulation by E2F6
TP53 tumor protein p53
  • Activation of NOXA and translocation to mitochondria
  • Activation of PUMA and translocation to mitochondria
  • Pre-NOTCH Transcription and Translation
  • Oxidative Stress Induced Senescence
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Oncogene Induced Senescence
  • DNA Damage/Telomere Stress Induced Senescence
  • SUMOylation of transcription factors
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Association of TriC/CCT with target proteins during biosynthesis
  • Pyroptosis
  • TP53 Regulates Metabolic Genes
  • Ub-specific processing proteases
  • Ovarian tumor domain proteases
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Interleukin-4 and Interleukin-13 signaling
  • TP53 Regulates Transcription of DNA Repair Genes
  • TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
  • TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
  • TP53 Regulates Transcription of Caspase Activators and Caspases
  • TP53 Regulates Transcription of Death Receptors and Ligands
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
  • TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
  • Regulation of TP53 Expression
  • Regulation of TP53 Activity through Phosphorylation
  • Regulation of TP53 Degradation
  • Regulation of TP53 Activity through Acetylation
  • Regulation of TP53 Activity through Association with Co-factors
  • Regulation of TP53 Activity through Methylation
  • PI5P Regulates TP53 Acetylation
  • G2/M DNA damage checkpoint
  • G2/M Checkpoints
  • Stabilization of p53
  • Transcriptional activation of cell cycle inhibitor p21
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • Transcriptional Regulation by VENTX
  • RUNX3 regulates CDKN1A transcription
  • Regulation of PTEN gene transcription
  • Regulation of PTEN gene transcription
  • Loss of function of TP53 in cancer due to loss of tetramerization ability
  • Signaling by ALK fusions and activated point mutants
  • Regulation of NF-kappa B signaling
  • Zygotic genome activation (ZGA)
  • Factors involved in megakaryocyte development and platelet production
  • PKR-mediated signaling
  • Acetylsalicylic acid
  • Zinc
  • Triethyl phosphate
  • AZD 3355
  • 1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Chronic myeloid leukemia (CML)
  • Breast cancer
  • Non-small cell lung cancer
  • Gastric cancer
  • Adult T-cell leukemia
  • Choriocarcinoma
  • Esophageal cancer
  • Glioma
  • Pancreatic cancer
  • Vulvar cancer
  • Multiple myeloma
  • Choroid plexus papilloma
  • Ovarian cancer
  • Hepatocellular carcinoma
  • Squamous cell carcinoma
  • Endometrial Cancer
  • Penile cancer
  • Cancer of the anal canal
  • Hairy-cell leukemia
  • Oral cancer
  • Adrenal carcinoma
  • Malignant melanoma
  • Burkitt lymphoma
  • Thyroid cancer
  • Basal cell carcinoma
  • Small cell lung cancer
  • Gallbladder cancer
  • Bladder cancer
  • Laryngeal cancer
  • Kaposi's sarcoma
  • Cholangiocarcinoma
  • Chronic lymphocytic leukemia (CLL)
  • Li-Fraumeni syndrome, including: Classic Li-Fraumeni syndrome (LFS); LFS-like syndrome (LFSL)
  • Malignant pleural mesothelioma
  • Osteosarcoma
  • Colorectal cancer
TP53BP1 tumor protein p53 binding protein 1
  • SUMOylation of transcription factors
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Nonhomologous End-Joining (NHEJ)
  • Processing of DNA double-strand break ends
  • G2/M DNA damage checkpoint

Page 2 out of 2 pages